Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AALLON GROUP OYJ AALLON Jan 15, 2021 11.10 -0.89   
 Admicom Oyj ADMCM Jan 15, 2021 118.50 -5.95   
 Afarak Group AFAGR Jan 15, 2021 0.22 -0.89   
 Ahlstrom-Munksj÷ AM1 Jan 15, 2021 18.20 +0.66   
 Ahola Transport AHOLA Jan 15, 2021 1.61 -0.62   
 Aktia Bank AKTIA Jan 15, 2021 9.70 -1.92   
 Alma Media ALMA Jan 15, 2021 9.40 +1.08   
 Altia ALTIA Jan 15, 2021 10.04 +1.41   
 Apetit APETIT Jan 15, 2021 12.95 -1.89   
 Aspo ASPO Jan 15, 2021 8.62 -0.46   
 Aspocomp Group ACG1V Jan 15, 2021 3.95 -5.50   
 Atria A ATRAV Jan 15, 2021 10.48 -0.76   
 Basware BAS1V Jan 15, 2021 41.95 -0.12   
 BBS-Bioactive Bone Substitutes BONEH Jan 15, 2021 4.00 0.00   
 Bilot Plc BILOT Jan 15, 2021 9.44 +6.79   
 Biohit B BIOBV Jan 15, 2021 2.20 -1.35   
 Bittium BITTI Jan 15, 2021 5.88 -0.17   
 CapMan CAPMAN Jan 15, 2021 2.38 -0.42   
 Cargotec CGCBV Jan 15, 2021 34.60 -2.09   
 Caverion CAV1V Jan 15, 2021 6.03 -0.66   
 Citycon CTY1S Jan 15, 2021 7.90 +0.38   
 Componenta CTH1V Jan 15, 2021 3.08 +0.39   
 Consti Plc CONSTI Jan 15, 2021 9.80 +1.66   
 Detection Technology DETEC Jan 15, 2021 26.00 -3.70   
 Digia DIGIA Jan 15, 2021 7.48 -2.09   
 Digitalist Group DIGIGR Jan 15, 2021 0.04 -4.35   
 Dovre Group DOV1V Jan 15, 2021 0.28 -0.35   
 EAB Group EAB Jan 15, 2021 3.28 -0.61   
 Eezy Oyj EEZY Jan 15, 2021 5.74 +0.70   
 Efecte PLC EFECTE Jan 15, 2021 12.30 -0.81   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK